Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 7025, September 1, 2008. doi: 10.1158/0008-5472.CAN-08-0806
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, T.
Right arrow Articles by Lin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, T.
Right arrow Articles by Lin, D.

Epidemiology

Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer

Tong Sun1, Yifeng Zhou1, Ming Yang1, Zhibin Hu3, Wen Tan1, Xiaohong Han2, Yuankai Shi2, Jiarui Yao2, Yongli Guo1, Dianke Yu1, Tian Tian3, Xiaoyi Zhou3, Hongbing Shen3 and Dongxin Lin1

Departments of 1 Etiology and Carcinogenesis and 2 Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 3 Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing, China

Requests for reprints: Dongxin Lin, Departments of Etiology & Carcinogenesis, Cancer Institute, Chinese Academy of Medical Sciences, Beijing 100021, China. Phone: 8610-877-88491; Fax: 8610-677-22460; E-mail: dlin{at}public.bta.net.cn or Hongbing Shen, Department of Epidemiology and Biostatistics, Cancer Center, Nanjing Medical University, Nanjing 210029, China. Phone: 86-25-868-62756; Fax: 86-25-868-62756; E-mail: hbshen{at}njmu.edu.cn.

Key Words: CTLA-4 • polymorphism • cancer susceptibility • association study • T cell

Antitumor T lymphocytes play a pivotal role in immunosurveillance of malignancy. The CTL antigen 4 (CTLA-4) is a vital negative regulator of T-cell activation and proliferation. This study examined whether genetic polymorphisms in CTLA-4 are associated with cancer susceptibility. A two-stage investigation using haplotype-tagging single nucleotide polymorphism approach and multiple independent case-control analyses was performed to assess the association between CTLA-4 genotypes and cancer risk. Functional relevance of the polymorphisms was examined by biochemical assays. We found that the 49G>A polymorphism in the CTLA-4 leading sequence causing 17Ala to 17Thr amino acid substitution is associated with increased susceptibility to multiple cancers, including lung, breast, esophagus, and gastric cardia cancers. Genotyping in 5,832 individuals with cancer and 5,831 control subjects in northern and southern Chinese populations showed that the CTLA-4 49AA genotype had an odds ratio of 1.72 (95% confidence interval, 1.50–2.10; P = 3.4 x 10–7) for developing cancer compared with the 49GG genotype. Biochemical analyses showed that CTLA-4–17Thr had higher capability to bind B7.1 and stronger inhibitory effect on T-cell activation compared with CTLA-4–17Ala. T cells carrying the 49AA genotype had significantly lower activation and proliferation rates compared with T cells carrying the 49GG genotype upon stimulation. These results are consistent with our hypothesis and indicate that genetic polymorphisms influencing T-cell activation modify cancer susceptibility. [Cancer Res 2008;68(17):7025–34]




This article has been cited by other articles:


Home page
Eur Respir JHome page
G. Zhu, A. Agusti, A. Gulsvik, P. Bakke, H. Coxson, D. A. Lomas, E. K. Silverman, S. G. Pillai, and ICGN investigators
CTLA4 gene polymorphisms are associated with chronic bronchitis
Eur. Respir. J., September 1, 2009; 34(3): 598 - 604.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Sun, Z. Hu, H. Shen, and D. Lin
Genetic Polymorphisms in Cytotoxic T-Lymphocyte Antigen 4 and Cancer: The Dialectical Nature of Subtle Human Immune Dysregulation
Cancer Res., August 1, 2009; 69(15): 6011 - 6014.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Wu, Z. Hu, D. Yu, L. Huang, G. Jin, J. Liang, H. Guo, W. Tan, M. Zhang, J. Qian, et al.
Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations
Cancer Res., June 15, 2009; 69(12): 5065 - 5072.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.